VEA
NUVB icon

Virtus ETF Advisers’s Nuvation Bio NUVB Stock Holding History

Virtus ETF Advisers’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-27,031
Closed -$71.9K – 666
2024
Q4 		$71.9K Sell
27,031
-3,790
-12% -$9.76K 0.03% 358
2024
Q3 		$70.6K Buy
30,821
+545
+2% +$1.66K 0.03% 427
2024
Q2 		$88.4K Buy
+30,276
New +$92.4K 0.04% 369
2023
Q2 		– Sell
-56,210
Closed -$93.3K – 469
2023
Q1 		$93.3K Sell
56,210
-21,606
-28% -$43.8K 0.05% 353
2022
Q4 		$149K Buy
77,816
+47,366
+156% +$95.8K 0.08% 346
2022
Q3 		$68K Buy
30,450
+216
+0.7% +$617 0.03% 432
2022
Q2 		$98K Buy
30,234
+14,200
+89% +$61.9K 0.04% 429
2022
Q1 		$84K Sell
16,034
-952
-6% -$5.35K 0.04% 332
2021
Q4 		$144K Sell
16,986
-1,654
-9% -$15.2K 0.05% 357
2021
Q3 		$185K Sell
18,640
-964
-5% -$8.74K 0.08% 289
2021
Q2 		$183K Buy
+19,604
New +$224K 0.08% 383

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return

Virtus ETF Advisers's NUVB Position: Q1 2025 in Review

Virtus ETF Advisers sold out of Nuvation Bio (NUVB) in Q1 2025, closing a stake of 27,031 shares — an estimated $71.9K sold.

Virtus ETF Advisers first reported a position in NUVB in Q2 2021 and held it in 11 quarters. The position peaked at $185K in Q3 2021. 161 funds tracked by Wall St. Rank hold NUVB as of Q1 2025.

  • Virtus ETF Advisers reported no remaining Nuvation Bio position as of Q1 2025 after selling out during the quarter.
  • Virtus ETF Advisers sold 27,031 Nuvation Bio shares in Q1 2025, an estimated $71.9K.
  • Virtus ETF Advisers first reported a position in Nuvation Bio in Q2 2021 and held it in 11 quarters.
  • Virtus ETF Advisers's Nuvation Bio position peaked at $185K in Q3 2021.
  • 161 funds tracked by Wall St. Rank held Nuvation Bio as of Q1 2025.

Based on Virtus ETF Advisers's 13F filing for Q1 2025, filed 14 May 2025.